Comparative in Vitro Activity of Augmentin Against Community and Hospital-Acquired Gram-Negative Bacteria
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 43 (2) , 109-114
- https://doi.org/10.1080/17843286.1988.11717917
Abstract
The susceptibility of 841 unselectcd, gramnegative bacterial isolates to augmentin, an amoxycillin/clavulanic acid formulation, was examined and compared with their sensitivity to other antibiotics. Susceptibility was measured using a disk diffusion procedure. Augmentin showed a high degree of activity against the folates tested. Overall rates of sensitivity, intermediate sensitivity, and resistance to augmentin among the Enlerobacleriaceae were 81.6%, 7.6%, and 10.8%, respectively. As expected, a considerably higher degree of resistance occured to ampicillin (58.4 %). The antibacterial pattern augmentin compared favourably with that of the second-generation cephalosporin, cefuroxime. These results indicate that augmentin is likely to be clinically active against a conquerable number of community and hospital-acquired gram-negative strains.This publication has 0 references indexed in Scilit: